Welch & Forbes’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,750
| Closed | -$1.37M | – | 361 |
|
|
2019
Q3 | $1.37M | Sell |
13,750
-6,857
| -33% | -$652K | 0.03% | 188 |
|
|
2019
Q2 | $1.91M | Sell |
20,607
-11,991
| -37% | -$1.14M | 0.05% | 165 |
|
|
2019
Q1 | $3.08M | Sell |
32,598
-94,687
| -74% | -$8.28M | 0.08% | 146 |
|
|
2018
Q4 | $8.16M | Sell |
127,285
-70,595
| -36% | -$5.21M | 0.23% | 100 |
|
|
2018
Q3 | $17.7M | Sell |
197,880
-3,952
| -2% | -$349K | 0.42% | 72 |
|
|
2018
Q2 | $16M | Sell |
201,832
-90,512
| -31% | -$7.52M | 0.41% | 73 |
|
|
2018
Q1 | $26.1M | Buy |
292,344
+17,468
| +6% | +$1.68M | 0.67% | 51 |
|
|
2017
Q4 | $28.7M | Buy |
274,876
+10,277
| +4% | +$1.16M | 0.77% | 43 |
|
|
2017
Q3 | $38.6M | Buy |
264,599
+6,126
| +2% | +$834K | 1.02% | 33 |
|
|
2017
Q2 | $33.6M | Buy |
258,473
+8,145
| +3% | +$998K | 0.94% | 33 |
|
|
2017
Q1 | $31.1M | Buy |
250,328
+8,506
| +4% | +$1.02M | 0.89% | 35 |
|
|
2016
Q4 | $28M | Buy |
241,822
+13,584
| +6% | +$1.51M | 0.84% | 38 |
|
|
2016
Q3 | $23.9M | Sell |
228,238
-2,487
| -1% | -$269K | 0.83% | 40 |
|
|
2016
Q2 | $22.8M | Buy |
230,725
+6,704
| +3% | +$693K | 0.69% | 49 |
|
|
2016
Q1 | $22.4M | Buy |
224,021
+19,794
| +10% | +$2.04M | 0.7% | 48 |
|
|
2015
Q4 | $24.5M | Buy |
204,227
+3,986
| +2% | +$461K | 0.78% | 42 |
|
|
2015
Q3 | $21.7M | Buy |
200,241
+14,444
| +8% | +$1.79M | 0.72% | 44 |
|
|
2015
Q2 | $21.5M | Buy |
185,797
+1,131
| +0.6% | +$129K | 0.67% | 49 |
|
|
2015
Q1 | $21.3M | Buy |
184,666
+6,018
| +3% | +$719K | 0.64% | 55 |
|
|
2014
Q4 | $20M | Buy |
178,648
+7,191
| +4% | +$758K | 0.59% | 61 |
|
|
2014
Q3 | $16.3M | Buy |
171,457
+11,588
| +7% | +$1.05M | 0.5% | 71 |
|
|
2014
Q2 | $13.7M | Buy |
159,869
+14,307
| +10% | +$1.09M | 0.43% | 72 |
|
|
2014
Q1 | $10.2M | Buy |
145,562
+91,498
| +169% | +$7.25M | 0.32% | 87 |
|
|
2013
Q4 | $4.57M | Buy |
54,064
+31,656
| +141% | +$2.5M | 0.14% | 124 |
|
|
2013
Q3 | $1.73M | Buy |
22,408
+17,128
| +324% | +$1.2M | 0.06% | 168 |
|
|
2013
Q2 | $309K | Buy |
+5,280
| New | +$318K | 0.01% | 268 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Welch & Forbes's CELG Position: Q4 2019 in Review
Welch & Forbes sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,750 shares — an estimated $1.37M sold.
Welch & Forbes first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $38.6M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Welch & Forbes reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Welch & Forbes sold 13,750 Celgene Corp shares in Q4 2019, an estimated $1.37M.
- Welch & Forbes first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Welch & Forbes's Celgene Corp position peaked at $38.6M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Welch & Forbes's 13F filing for Q4 2019, filed 17 Jan 2020.